These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28438936)

  • 1. Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei.
    Barnes KB; Hamblin KA; Richards MI; Laws TR; Vente A; Atkins HS; Harding SV
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438936
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of finafloxacin, a novel fluoroquinolone with increased activity at acid pH, towards extracellular and intracellular Staphylococcus aureus, Listeria monocytogenes and Legionella pneumophila.
    Lemaire S; Van Bambeke F; Tulkens PM
    Int J Antimicrob Agents; 2011 Jul; 38(1):52-9. PubMed ID: 21596526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of pH on the activity of finafloxacin against extracellular and intracellular Burkholderia thailandensis, Yersinia pseudotuberculosis and Francisella philomiragia and on its cellular pharmacokinetics in THP-1 monocytes.
    Chalhoub H; Harding SV; Tulkens PM; Van Bambeke F
    Clin Microbiol Infect; 2020 Sep; 26(9):1254.e1-1254.e8. PubMed ID: 31404671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of finafloxacin in a murine model of inhalational glanders.
    Barnes KB; Bayliss M; Davies C; Richards MI; Laws TR; Vente A; Harding SV
    Front Microbiol; 2022; 13():1057202. PubMed ID: 36504783
    [No Abstract]   [Full Text] [Related]  

  • 5. Layering vaccination with antibiotic therapy results in protection and clearance of
    Barnes KB; Brett P; Burtnick M; Vente A; Bentley C; Richards MI; Flick-Smith HC; Burgess G; Thwaite JE; Laws TR; Maishman TC; Nelson M; Harding SV
    Infect Immun; 2024 Mar; 92(3):e0045523. PubMed ID: 38289122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro spectrum of activity of finafloxacin, a novel, pH-activated fluoroquinolone, under standard and acidic conditions.
    Stubbings W; Leow P; Yong GC; Goh F; Körber-Irrgang B; Kresken M; Endermann R; Labischinski H
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4394-7. PubMed ID: 21709094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of the investigational fluoroquinolone finafloxacin against ciprofloxacin-sensitive and -resistant Acinetobacter baumannii isolates.
    Higgins PG; Stubbings W; Wisplinghoff H; Seifert H
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1613-5. PubMed ID: 20100879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activity of finafloxacin against staphylococci displaying normal and small colony variant phenotypes.
    Idelevich EA; Kriegeskorte A; Stubbings W; Kahl BC; Peters G; Becker K
    J Antimicrob Chemother; 2011 Dec; 66(12):2809-13. PubMed ID: 21948963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of a combination therapy approach for the treatment of melioidosis.
    Barnes KB; Richards MI; Burgess G; Armstrong SJ; Bentley C; Maishman TC; Laws TR; Nelson M; Harding SV
    Front Microbiol; 2022; 13():934312. PubMed ID: 36051754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin/clavulanic acid and co-trimoxazole.
    Sivalingam SP; Sim SH; Jasper LC; Wang D; Liu Y; Ooi EE
    J Antimicrob Chemother; 2008 Mar; 61(3):674-8. PubMed ID: 18192684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim/sulfamethoxazole (co-trimoxazole) prophylaxis is effective against acute murine inhalational melioidosis and glanders.
    Barnes KB; Steward J; Thwaite JE; Lever MS; Davies CH; Armstrong SJ; Laws TR; Roughley N; Harding SV; Atkins TP; Simpson AJ; Atkins HS
    Int J Antimicrob Agents; 2013 Jun; 41(6):552-7. PubMed ID: 23517714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
    Feterl M; Govan B; Engler C; Norton R; Ketheesan N
    Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Delafloxacin against the Biothreat Pathogen Burkholderia pseudomallei.
    McCurdy S; Duffy E; Hickman M; Halasohoris S; Zumbrun SD
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0073621. PubMed ID: 34339266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders.
    Russell P; Eley SM; Ellis J; Green M; Bell DL; Kenny DJ; Titball RW
    J Antimicrob Chemother; 2000 Jun; 45(6):813-8. PubMed ID: 10837435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Delafloxacin against a Burkholderia pseudomallei Efflux Mutant Panel.
    McCurdy SP; Somprasong N; Schweizer HP
    Microbiol Spectr; 2022 Oct; 10(5):e0090322. PubMed ID: 35972245
    [No Abstract]   [Full Text] [Related]  

  • 16. Finafloxacin overcomes Burkholderia pseudomallei efflux-mediated fluoroquinolone resistance.
    Randall LB; Georgi E; Genzel GH; Schweizer HP
    J Antimicrob Chemother; 2017 Apr; 72(4):1258-1260. PubMed ID: 28039270
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of the investigational fluoroquinolone finafloxacin and seven other antimicrobial agents against 114 obligately anaerobic bacteria.
    Genzel GH; Stubbings W; Stîngu CS; Labischinski H; Schaumann R
    Int J Antimicrob Agents; 2014 Nov; 44(5):420-3. PubMed ID: 25264128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced susceptibility of Malaysian clinical isolates of Burkholderia pseudomallei to ciprofloxacin.
    Liew FY; Tay ST; Puthucheary SD
    Trop Biomed; 2011 Dec; 28(3):646-50. PubMed ID: 22433895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
    Crowe A; McMahon N; Currie BJ; Baird RW
    Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Investigation into the Re-Emergence of Disease Following Cessation of Antibiotic Treatment in Balb/c Mice Infected with Inhalational
    Laws TR; Barnes KB; Jenner DC; Núñez A; Richards MI; Thwaite JE; Vente A; Rushton D; Nelson M; Harding SV
    Antibiotics (Basel); 2022 Oct; 11(10):. PubMed ID: 36290100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.